Biocept (BIOC) Reports Q4 Loss of $0.24

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. SPY
10. FISV

Go back to Biocept (BIOC) Reports Q4 Loss of $0.24

Biocept (BIOC) Enters Agreement with PPO Network FedMed

March 9, 2016 7:33 AM EST

Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing assays for liquid biopsies to improve the detection and treatment of cancer, announces an agreement with preferred provider organization (PPO) network FedMed. FedMed members now have improved network access to Biocept's proprietary Target Selector liquid biopsy testing.

FedMed was founded in 2000 with corporate headquarters located... More